Women with cystic fibrosis (CF) who continue on CFTR modulator therapy during pregnancy show stable health and no…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
In an interview study, adults with cystic fibrosis who also developed diabetes reported that using a new type of…
Adults with cystic fibrosis (CF) and their healthcare providers generally agree that those living with stable disease while on…
Parent caregivers of people with cystic fibrosis (CF) want a tailored, internet-delivered resource offering mental health support, disease education,…
Kaftrio (elexacaftor/tezacaftor/ivacaftor) use was not associated with additional improvements in physical activity among children and adolescents with cystic…
Data from continuous glucose monitoring (CGM) devices, which track blood sugar levels in real time, can reveal early signs of…
Gene therapy using circular forms of DNA called plasmids may help treat lung disease in cystic fibrosis (CF), based…
Trikafta was associated with significant reductions in healthcare use, including hospitalizations related to cystic…
Children with cystic fibrosis (CF) who undergo a liver transplant alone have significantly better survival rates than those who receive…
Both youngsters and teenagers with cystic fibrosis (CF) have abnormal levels of bile acids, the main components of the…